NasdaqGS:IMPV

Stock Analysis Report

Executive Summary

Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide.

Snowflake

Fundamentals

Flawless balance sheet with reasonable growth potential.


Similar Companies

Share Price & News

How has Imperva's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.02%

NasdaqGS:IMPV

-3.0%

US Software

-1.0%

US Market


1 Year Return

25.8%

NasdaqGS:IMPV

18.5%

US Software

-0.4%

US Market

IMPV outperformed the Software industry which returned 15.3% over the past year.

IMPV outperformed the Market in United States of America which returned -7.7% over the past year.


Share holder returns

IMPVIndustryMarket
7 Day0.02%-3.0%-1.0%
30 Day0.5%-3.8%-3.3%
90 Day0.5%1.5%0.8%
1 Year25.8%25.8%20.2%18.5%1.9%-0.4%
3 Year3.1%3.1%115.2%106.7%39.4%30.4%
5 Year0.6%0.6%160.8%141.9%54.2%37.1%

Price Volatility Vs. Market

How volatile is Imperva's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Imperva undervalued based on future cash flows and its price relative to the stock market?

10%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Imperva's share price is below the future cash flow value, but not at a moderate discount (< 20%).

Imperva's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

Imperva is loss making, we can't compare its value to the US Software industry average.

Imperva is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Imperva, we can't assess if its growth is good value.


Price Based on Value of Assets

Imperva is overvalued based on assets compared to the US Software industry average.


Next Steps

Future Growth

How is Imperva expected to perform in the next 1 to 3 years based on estimates from 12 analysts?

59.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Imperva's revenue is expected to grow by 10.2% yearly, however this is not considered high growth (20% yearly).

Imperva's earnings are expected to grow significantly at over 20% yearly.

Imperva's revenue growth is expected to exceed the United States of America market average.

Imperva's earnings growth is expected to exceed the United States of America market average.

Imperva's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Imperva is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Imperva performed over the past 5 years?

17.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Imperva does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Imperva's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Imperva's 1-year growth to the US Software industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Imperva has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Imperva has efficiently used its assets last year compared to the US Software industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Imperva improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Imperva's financial position?


Financial Position Analysis

Imperva is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Imperva's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Imperva has no debt.

Imperva has not taken on any debt in the past 5 years.


Balance Sheet

Low level of unsold assets.

Imperva has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Whilst loss making Imperva has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.

Whilst loss making Imperva has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -27.3% per year.


Next Steps

Dividend

What is Imperva's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Imperva's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Imperva's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Imperva has not reported any payouts.

Unable to verify if Imperva's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Imperva has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Imperva's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Imperva's salary, the management and board of directors tenure and is there insider trading?

1.3yrs

Average management tenure


CEO

Chris Hylen (57yo)

1.4yrs

Tenure

US$5,094,625

Compensation

Mr. Christopher S. Hylen, also known as Chris, has been Chief Executive Officer, President and Director at Imperva, Inc. since August 15, 2017. Mr. Hylen served as Chief Executive Officer and President at  ...


CEO Compensation Analysis

Chris's remuneration is higher than average for companies of similar size in United States of America.

Insufficient data for Chris to compare compensation growth.


Management Age and Tenure

1.3yrs

Average Tenure

51.5yo

Average Age

The average tenure for the Imperva management team is less than 2 years, this suggests a new team.


Board Age and Tenure

2.4yrs

Average Tenure

64.5yo

Average Age

The average tenure for the Imperva board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month insider trading information.


Ownership Breakdown


Management Team

  • Trâm Phi (47yo)

    Chief Legal Officer & Chief of Staff

    • Tenure: 0.0yrs
    • Compensation: US$1.98m
  • Aharon Strosberg

    Vice President of Operations

    • Tenure: 11.3yrs
  • Dave Woodcock

    Senior Vice President of Worldwide Sales

    • Tenure: 0.8yrs
  • Mike Burns (52yo)

    Chief Financial Officer & Treasurer

    • Tenure: 1.0yrs
  • David Gee (51yo)

    Chief Marketing Officer

    • Tenure: 1.0yrs
  • Chris Hylen (57yo)

    President

    • Tenure: 1.4yrs
    • Compensation: US$5.09m
  • Terry Ray

    Chief Technology Officer

    • Tenure: 1.5yrs
  • Sunil Shah

    Vice President of Investor Relations

    • Tenure: 0.0yrs
  • Rachel Mann

    Vice President of Communications

    • Tenure: 1.3yrs
  • Shu White

    General Council & Assistant Secretary

    • Tenure: 0.0yrs

Board Members

  • Roger Sippl (63yo)

    Director

    • Tenure: 2.1yrs
    • Compensation: US$241.65k
  • James Tolonen (68yo)

    Director

    • Tenure: 6.5yrs
    • Compensation: US$253.99k
  • Allan Tessler (81yo)

    Chairman of the Board

    • Tenure: 0.9yrs
    • Compensation: US$251.52k
  • Albert Pimentel (63yo)

    Director

    • Tenure: 8.6yrs
    • Compensation: US$237.99k
  • Randy Spratt (66yo)

    Director

    • Tenure: 2.7yrs
    • Compensation: US$241.65k
  • Chris Hylen (57yo)

    President

    • Tenure: 1.4yrs
    • Compensation: US$5.09m

Company Information

Imperva, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Imperva, Inc.
  • Ticker: IMPV
  • Exchange: NasdaqGS
  • Founded: 2002
  • Industry: Systems Software
  • Sector: Software
  • Market Cap: US$1.973b
  • Shares outstanding: 35.44m
  • Website: https://www.imperva.com

Number of Employees


Location

  • Imperva, Inc.
  • 3400 Bridge Parkway
  • Suite 200
  • Redwood Shores
  • California
  • 94065
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IMPVNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDNov 2011
45IDB (Deutsche Boerse AG)YesCommon StockDEEURNov 2011

Biography

Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company’s Sec ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/01/15 00:31
End of Day Share Price2019/01/09 00:00
Earnings2018/09/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.